The role of cardiac troponin-I as a prognostic tool for mortality in patients hospitalized with COVID-19

26 August 2022 (08:00 - 19:30)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Jeni Quintal

Hospital Center of Setubal, Setubal (Portugal)

7 More presentations in this session

Presentation thumbnail

Expression changes of circulating ACE2 regulating-microRNA profiles in patients with COVID-19 during hospitalisation

Mrs C. Eyileten (Warsaw, PL)

Abstract Slides

Presentation thumbnail

Investigation of the effect of the angiotensin II type 2 receptor (AT2R) agonist C21 on plasma NT-proBNP, a diagnostic biomarker, in subjects hospitalised with COVID-19

Mrs E. Rosendahl (Solna, SE)

Abstract Slides

Presentation thumbnail

Long COVID-19 syndrome: association of cardiopulmonary impairment with a persistent platelet activation.

Associate Professor M. Camera (Milan, IT)

Abstract Slides

Presentation thumbnail

Dysregulation of cardiac endothelial lncRNA H19 in COVID19 patients induces endothelial dysfunction, which impairs cardiomyocyte function

Doctor R. Juni (Amsterdam, NL)

Abstract Slides

Presentation thumbnail

Thrombosis-related miR-16-5p predicts the disease severity in patients hospitalised for COVID-19

Professor M. Postula (Warsaw, PL)

Abstract Slides

Access the full session

Session thumbnail

Cardiovascular aspects of COVID and long-COVID

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022

You may be interested in

Congress Presentation

Advancements and challenges in cardiovascular risk stratification: an overview of cardiac biomarkers

Congress Presentation

DETECT-Heart: biomarkers for screening of patients referred to the cardiovascular outpatient clinic

Webinar

Biomarkers of clinical utility in cardiovascular disease

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources